| Name | Market | Market CAP | Share price | Daily share movement |
|---|---|---|---|---|
| 600 Group | AIM | £9.69 m | 8.25 GBX | -2.94% |
| 712 North | Unlisted | 0.00 | 0.00% | |
| 7D Surgical | Unlisted | 0.00 | 0.00% | |
| 7Digital Group PLC | AIM | £37.77 m | 1.39 GBX | 2.78% |
| 808 Renewable Energy Corp. | PINK | $27.64 m | 0.40 USD | 0.00% |
| 88 Energy Ltd | AIM | £559.43 k | 0.48 GBX | 1.06% |
| 888 Holdings | LSE | £1.12 billion | 302.35 GBX | -0.38% |
| 8common | ASX | $33.07 m | 0.17 AUD | -8.33% |
| 8I Holdings Limited | ASX | $63.31 m | 0.18 AUD | 0.00% |
| 8x8 Inc | NYSE | $3.57 billion | 33.25 USD | -0.30% |
| 9 Spokes International Ltd | ASX | $34.35 m | 0.02 AUD | 0.00% |
| 99 Bitcoins | Unlisted (US) | 0.00 | 0.00% | |
| 99 Wuxian Ltd | ASX | 0.00 | 0.00% | |
| A&J Mucklow Group PLC | LSE | 0.00 | 0.00% | |
| A-Cap Resources Ltd | ASX | $34 m | 0.04 AUD | -2.50% |
| A-Mark Precious Metals Inc | NASDAQ | $195.86 m | 27.22 USD | -1.52% |
| A.I.S. Resources Limited | TSX-V | 0.00 | 0.00% | |
| A.O. Smith | NYSE | $9.74 billion | 60.23 USD | -1.75% |
| A.T. Cross | NASDAQ | 0.00 | 0.00% | |
| A1 Consolidated Gold | ASX | 0.00 | 0.00% | |
| A1 Investments & Resources | ASX | $16.42 m | 0.00 AUD | 0.00% |
| A10 Networks Inc | NYSE | $701.62 m | 9.19 USD | -3.87% |
| A123 Systems | NASDAQ | $366.84 m | 13.65 USD | 0.04% |
| A2 Milk Co Ltd. | PINK | $5.25 billion | 7.08 USD | -15.71% |
| AA PLC | LSE | £217.64 m | 34.90 GBX | 0.29% |
| AAC Clyde Space AB | OTCQX | $63.3 m | 0.43 USD | 2.50% |
| AAC Holdings Inc. | PINK | $0.00 | 0.00 USD | 0.00% |
| AAR | NYSE | $1.41 billion | 39.95 USD | -6.59% |
| AB Dynamics PLC | AIM | £426.18 m | 1,887.00 GBX | 1.45% |
| AB Science, Paris | PINK | $822.32 m | 18.54 USD | -3.25% |
| AB&T Financial Corp. (NC) | PINK | $960.55 k | 0.36 USD | -20.00% |
| Abacus Health Products, Inc. | CSE | 0.00 | 0.00% | |
| Abacus Mining & Exploration Corp. | TSX-V | $11.1 m | 0.15 CAD | 3.45% |
| Abacus Property Group | ASX | $2.18 billion | 2.71 AUD | -1.09% |
| Abal Group PLC | Unlisted | 0.00 | 0.00% | |
| Abattis Bioceuticals | CSE | 0.00 | 0.00% | |
| Abbey plc | AIM | £334.03 m | 1,600.00 GBX | 0.00% |
| Abbey Protection | Unlisted (UK) | 0.00 | 0.00% | |
| Abbeycrest | LSE | 0.00 | 0.00% | |
| Abbott Laboratories | NYSE | $215.38 billion | 121.58 USD | -0.65% |